# Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate

> **NCT05750576** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 270 (actual)

## Conditions studied

- Cardiogenic Shock
- Extracorporeal Membrane Oxygenation Complication
- Acute Respiratory Distress Syndrome
- Infections

## Interventions

- **DEVICE:** Chlorhexidine-impregnated dressings
- **DEVICE:** Non impregnated dressings

## Key facts

- **NCT ID:** NCT05750576
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-15
- **Primary completion:** 2025-06-20
- **Final completion:** 2025-06-20
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750576, "Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05750576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*